Anti-cancer drugs which intercalate into DNA: How do they act?
- 30 June 1983
- journal article
- review article
- Published by Elsevier in Trends in Biochemical Sciences
- Vol. 8 (6), 212-214
- https://doi.org/10.1016/0968-0004(83)90215-3
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Alkylation-induced sister-chromatic exchanges correlate with reduced cell survival, not mutationsMutation Research Letters, 1982
- Ellipticine-induced protein-associated DNA breaks in isolated L1210 nucleiBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1982
- The nature of DNA breakage by 4'-[(9-acridinyl)amino]methane-sulphon-m -anisidideFEBS Letters, 1982
- The Anticancer Agent Adriamycin Can Be Actively Cytotoxic Without Entering CellsScience, 1982
- The formation and resealing of intercalator-induced DNA strand breaks in isolated L1210 cell nucleiBiochemical and Biophysical Research Communications, 1982
- A reassessment of the mechanism of action of 4′-[(9-acridinyl)-amino]methanesulphon-m-anisidideEuropean Journal of Cancer and Clinical Oncology, 1982
- Protein-associated deoxyribonucleic acid strand breaks in L1210 cells treated with the deoxyribonucleic acid intercalating agents 4'-(9-acridinylamino)methanesulfon-m-anisidide and adriamycinBiochemistry, 1981
- DNA double-strand breaks in mammalian cells after exposure to intercalating agentsBiochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1981
- DNA Modification and CancerAnnual Review of Biochemistry, 1981
- On the mechanism of action of 4′-[(9-acridinyl)-amino] methanesulphon-m-anisidideEuropean Journal of Cancer (1965), 1980